Effect of body iron stores on serum aluminum level in hemodialysis patients

J. Y. Huang, C. C. Huang, P. S. Lim, M. S. Wu, M. L. Leu

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

To evaluate the influence of body iron stores on the serum aluminum (Al) level, we studied the correlation between iron status (the serum ferritin, serum iron and transferrin saturation) and serum Al levels in 68 severely anemic hemodialysis patients. Among them, 36 underwent the desferrioxamine (DFO) mobilization test. These 68 patients were divided into three groups according to their serum ferritin level. The basal Al level in the patient group was 41.4 ± 37.4 μg/l (control, 4.1 ± 2.4 ug/l). The serum Al level after DFO infusion of the patient group was 111.1 ± 86.8 μg/l. A significantly higher basal Al and peak Al level after DFO infusion were found in group I patients (serum ferritin <300 μg/l) when compared to group 2 (serum ferritin 300-1,000 μg/l) and group 3 (serum ferritin > 1,000 μg/l) patients. A significant negative correlation between serum ferritin and basal serum Al (r = -0.544, p = 0.0001), as well as peak serum Al after DFO infusion (r=-0.556, p= 0.0001), was noted. Similarly, a negative relationship between serum Al (both basal and peak) and either serum iron or transferrin saturation was noted. However, there was no correlation between the serum Al level and the dosage of aluminum hydroxide. In conclusion, serum ferritin, serum iron and transferrin saturation were inversely correlated with serum Al in our hemodialysis patients. Iron deficiency may probably increase Al accumulation in these patients.

Original languageEnglish
Pages (from-to)158-162
Number of pages5
JournalNephron
Volume61
Issue number2
Publication statusPublished - 1992
Externally publishedYes

Fingerprint

Aluminum
Renal Dialysis
Iron
Serum
Ferritins
Deferoxamine
Transferrin
Aluminum Hydroxide

Keywords

  • Aluminum
  • Desferrioxamine
  • Ferritin
  • Hemodialysis
  • Iron store

ASJC Scopus subject areas

  • Nephrology

Cite this

Huang, J. Y., Huang, C. C., Lim, P. S., Wu, M. S., & Leu, M. L. (1992). Effect of body iron stores on serum aluminum level in hemodialysis patients. Nephron, 61(2), 158-162.

Effect of body iron stores on serum aluminum level in hemodialysis patients. / Huang, J. Y.; Huang, C. C.; Lim, P. S.; Wu, M. S.; Leu, M. L.

In: Nephron, Vol. 61, No. 2, 1992, p. 158-162.

Research output: Contribution to journalArticle

Huang, JY, Huang, CC, Lim, PS, Wu, MS & Leu, ML 1992, 'Effect of body iron stores on serum aluminum level in hemodialysis patients', Nephron, vol. 61, no. 2, pp. 158-162.
Huang, J. Y. ; Huang, C. C. ; Lim, P. S. ; Wu, M. S. ; Leu, M. L. / Effect of body iron stores on serum aluminum level in hemodialysis patients. In: Nephron. 1992 ; Vol. 61, No. 2. pp. 158-162.
@article{b2b57eb9027842008821791cf6b7a42d,
title = "Effect of body iron stores on serum aluminum level in hemodialysis patients",
abstract = "To evaluate the influence of body iron stores on the serum aluminum (Al) level, we studied the correlation between iron status (the serum ferritin, serum iron and transferrin saturation) and serum Al levels in 68 severely anemic hemodialysis patients. Among them, 36 underwent the desferrioxamine (DFO) mobilization test. These 68 patients were divided into three groups according to their serum ferritin level. The basal Al level in the patient group was 41.4 ± 37.4 μg/l (control, 4.1 ± 2.4 ug/l). The serum Al level after DFO infusion of the patient group was 111.1 ± 86.8 μg/l. A significantly higher basal Al and peak Al level after DFO infusion were found in group I patients (serum ferritin <300 μg/l) when compared to group 2 (serum ferritin 300-1,000 μg/l) and group 3 (serum ferritin > 1,000 μg/l) patients. A significant negative correlation between serum ferritin and basal serum Al (r = -0.544, p = 0.0001), as well as peak serum Al after DFO infusion (r=-0.556, p= 0.0001), was noted. Similarly, a negative relationship between serum Al (both basal and peak) and either serum iron or transferrin saturation was noted. However, there was no correlation between the serum Al level and the dosage of aluminum hydroxide. In conclusion, serum ferritin, serum iron and transferrin saturation were inversely correlated with serum Al in our hemodialysis patients. Iron deficiency may probably increase Al accumulation in these patients.",
keywords = "Aluminum, Desferrioxamine, Ferritin, Hemodialysis, Iron store",
author = "Huang, {J. Y.} and Huang, {C. C.} and Lim, {P. S.} and Wu, {M. S.} and Leu, {M. L.}",
year = "1992",
language = "English",
volume = "61",
pages = "158--162",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Effect of body iron stores on serum aluminum level in hemodialysis patients

AU - Huang, J. Y.

AU - Huang, C. C.

AU - Lim, P. S.

AU - Wu, M. S.

AU - Leu, M. L.

PY - 1992

Y1 - 1992

N2 - To evaluate the influence of body iron stores on the serum aluminum (Al) level, we studied the correlation between iron status (the serum ferritin, serum iron and transferrin saturation) and serum Al levels in 68 severely anemic hemodialysis patients. Among them, 36 underwent the desferrioxamine (DFO) mobilization test. These 68 patients were divided into three groups according to their serum ferritin level. The basal Al level in the patient group was 41.4 ± 37.4 μg/l (control, 4.1 ± 2.4 ug/l). The serum Al level after DFO infusion of the patient group was 111.1 ± 86.8 μg/l. A significantly higher basal Al and peak Al level after DFO infusion were found in group I patients (serum ferritin <300 μg/l) when compared to group 2 (serum ferritin 300-1,000 μg/l) and group 3 (serum ferritin > 1,000 μg/l) patients. A significant negative correlation between serum ferritin and basal serum Al (r = -0.544, p = 0.0001), as well as peak serum Al after DFO infusion (r=-0.556, p= 0.0001), was noted. Similarly, a negative relationship between serum Al (both basal and peak) and either serum iron or transferrin saturation was noted. However, there was no correlation between the serum Al level and the dosage of aluminum hydroxide. In conclusion, serum ferritin, serum iron and transferrin saturation were inversely correlated with serum Al in our hemodialysis patients. Iron deficiency may probably increase Al accumulation in these patients.

AB - To evaluate the influence of body iron stores on the serum aluminum (Al) level, we studied the correlation between iron status (the serum ferritin, serum iron and transferrin saturation) and serum Al levels in 68 severely anemic hemodialysis patients. Among them, 36 underwent the desferrioxamine (DFO) mobilization test. These 68 patients were divided into three groups according to their serum ferritin level. The basal Al level in the patient group was 41.4 ± 37.4 μg/l (control, 4.1 ± 2.4 ug/l). The serum Al level after DFO infusion of the patient group was 111.1 ± 86.8 μg/l. A significantly higher basal Al and peak Al level after DFO infusion were found in group I patients (serum ferritin <300 μg/l) when compared to group 2 (serum ferritin 300-1,000 μg/l) and group 3 (serum ferritin > 1,000 μg/l) patients. A significant negative correlation between serum ferritin and basal serum Al (r = -0.544, p = 0.0001), as well as peak serum Al after DFO infusion (r=-0.556, p= 0.0001), was noted. Similarly, a negative relationship between serum Al (both basal and peak) and either serum iron or transferrin saturation was noted. However, there was no correlation between the serum Al level and the dosage of aluminum hydroxide. In conclusion, serum ferritin, serum iron and transferrin saturation were inversely correlated with serum Al in our hemodialysis patients. Iron deficiency may probably increase Al accumulation in these patients.

KW - Aluminum

KW - Desferrioxamine

KW - Ferritin

KW - Hemodialysis

KW - Iron store

UR - http://www.scopus.com/inward/record.url?scp=0026594308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026594308&partnerID=8YFLogxK

M3 - Article

C2 - 1630539

AN - SCOPUS:0026594308

VL - 61

SP - 158

EP - 162

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 2

ER -